A detailed history of Black Rock Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,485,931 shares of NTRA stock, worth $690 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,485,931
Previous 6,305,838 2.86%
Holding current value
$690 Million
Previous $395 Million 50.18%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$59.21 - $92.9 $10.7 Million - $16.7 Million
180,093 Added 2.86%
6,485,931 $593 Million
Q4 2023

Feb 13, 2024

BUY
$37.55 - $62.64 $20.7 Million - $34.6 Million
552,125 Added 9.6%
6,305,838 $395 Million
Q3 2023

Nov 13, 2023

SELL
$43.4 - $62.52 $11.5 Million - $16.5 Million
-263,844 Reduced 4.38%
5,753,713 $255 Million
Q2 2023

Aug 11, 2023

BUY
$47.08 - $55.16 $23.9 Million - $28 Million
508,173 Added 9.22%
6,017,557 $293 Million
Q1 2023

May 12, 2023

SELL
$36.57 - $58.29 $2.1 Million - $3.35 Million
-57,555 Reduced 1.03%
5,509,384 $306 Million
Q4 2022

Feb 13, 2023

BUY
$34.17 - $47.91 $22.4 Million - $31.4 Million
656,130 Added 13.36%
5,566,939 $224 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $6.04 Million - $9.26 Million
163,446 Added 3.44%
4,910,809 $215 Million
Q2 2022

Aug 12, 2022

SELL
$28.13 - $44.54 $31.3 Million - $49.6 Million
-1,114,369 Reduced 19.01%
4,747,363 $168 Million
Q1 2022

May 12, 2022

SELL
$30.32 - $91.33 $34.8 Million - $105 Million
-1,149,025 Reduced 16.39%
5,861,732 $238 Million
Q4 2021

Feb 10, 2022

BUY
$86.26 - $119.0 $3.88 Million - $5.36 Million
45,036 Added 0.65%
7,010,757 $655 Million
Q3 2021

Nov 09, 2021

BUY
$100.17 - $126.36 $133 Million - $168 Million
1,331,023 Added 23.62%
6,965,721 $776 Million
Q2 2021

Aug 11, 2021

BUY
$86.05 - $119.72 $485 Million - $675 Million
5,634,698 New
5,634,698 $640 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.